Semax and Selank are often searched together because both are short neuropeptide research materials with origins in Russian peptide research programs. For a research supplier, the safest and most useful way to compare them is not through consumer claims or protocol language. It is through documentation: sequence identity, molecular weight, purity testing, mass spectrometry confirmation, storage labeling, and batch-matched COAs.
This guide explains how to review Semax COA and Selank specifications from a procurement perspective. It is intended for researchers and lab buyers comparing documentation quality, not for personal use, dosing, diagnosis, treatment, or outcome guidance. Vespera products are strictly for research purposes only.
If you are comparing Semax vs Selank suppliers, start with the same question for both peptides: can the supplier connect the product page, vial label, lot number, HPLC purity data, and mass spectrometry identity data in one traceable record?
Peptide Identity and Specs
Short peptides can look deceptively simple on a product page. A complete research record should still identify the sequence, molecular weight basis, salt form when applicable, and batch-level analytical results.
Semax Identity Snapshot
Semax is commonly described as an ACTH(4-10) analog with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, often abbreviated MEHFPGP. Public chemical references commonly list the free peptide molecular weight around 813.9 Da, while supplier documents may show a different apparent value if a salt form, counterion, hydration state, or analytical ion is being reported.
For COA review, do not rely on the name alone. A Semax research peptide documentation record should state:
- Product name: Semax.
- Sequence: MEHFPGP, or the supplier's full written sequence.
- Theoretical molecular weight and the basis for that value.
- Observed mass from MS or LC-MS.
- HPLC purity result with method label.
- Lot or batch number.
View Vespera Semax research peptide or request available COA/spec documentation.
Selank Identity Snapshot
Selank is commonly described as a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, often abbreviated TKPRPGP. Public chemical references commonly list the free peptide molecular weight around 751.9 Da. As with Semax, the value on a supplier COA should be read in context: free peptide, salt form, observed ion, and report format can affect how mass is displayed.
A strong Selank purity research record should state:
- Product name: Selank.
- Sequence: TKPRPGP, or the supplier's full written sequence.
- Theoretical and observed mass.
- HPLC purity result.
- Batch or lot number.
- Document date and testing lab.
View Vespera Selank research peptide or request available COA/spec documentation.
Semax vs Selank: Documentation Comparison
The table below is designed for research procurement, not use guidance.
| Field | Semax | Selank | What to verify |
|---|---|---|---|
| Common sequence notation | MEHFPGP | TKPRPGP | Sequence should appear on supplier specification records |
| Typical length | 7 amino acids | 7 amino acids | Count should match the reported sequence |
| Approximate free peptide MW | About 813.9 Da | About 751.9 Da | COA should explain salt form or observed ion differences |
| Research category | Neuropeptide and ACTH-fragment research context | Neuropeptide and regulatory peptide research context | Supplier copy should stay research-only |
| Common documentation tests | HPLC purity and MS identity | HPLC purity and MS identity | Both tests should be batch traceable |
| Stability review | Short peptide, storage depends on format and supplier label | Short peptide, storage depends on format and supplier label | Follow documented storage label, not generic forum advice |
| Study protocol reporting | Original studies vary by model and design | Original studies vary by model and design | Supplier pages should not provide dosing instructions |
The most important comparison is not which peptide has a more appealing marketing description. It is whether the supplier can produce batch-matched documentation that supports the exact vial, SKU, and lot being reviewed.
What Researchers Usually Want to Know Before Reviewing a Semax or Selank Supplier
Clinic-style peptide pages are often easy to read because they answer practical questions in a direct order: what the product is, how it differs from related products, what a buyer should check, and what questions come up most often. Vespera should use that clarity, but with research-only boundaries.
For Semax and Selank, the safer research-supplier version of that structure looks like this:
| Buyer question | Vespera-safe answer format |
|---|---|
| What is it? | Sequence, molecular weight basis, product identity, and research category |
| How is Semax different from Selank? | Documentation comparison by sequence, MW, identity method, and supplier record |
| What should I verify? | HPLC purity, MS identity, lot number, COA date, and SKU match |
| What makes a supplier credible? | Batch-matched COA access, transparent support, and consistent product labels |
| What should I avoid? | Generic COAs, unsupported purity claims, missing MS, and use/outcome claims |
This keeps the page useful for real buyers without publishing dosing instructions, administration guidance, or consumer outcome claims.
Research-Only Product Page Sections That Work
For Semax and Selank product and article pages, the strongest sections are:
- Identity snapshot: sequence, molecular weight, product name, SKU, and format.
- Documentation checklist: COA, HPLC, MS, batch number, and document date.
- Comparison table: Semax vs Selank by analytical and catalog fields.
- Supplier questions: what to ask before accepting a COA.
- FAQ: concise answers about documentation, purity, mass spec, and lot matching.
Sections to avoid on a research peptide supplier site include user benefits, candidate profiles, expected effects, cycle length, dose ranges, nasal spray administration, and side-effect management. Those topics shift the page away from procurement documentation and into use guidance.
What a Proper COA Should Show
Semax and Selank COAs should follow the same core standard as other research peptide documentation: identity, purity, traceability, and method clarity.
Expected HPLC/MS Fields
A proper COA should show:
- Product name and SKU.
- Lot or batch number.
- Test date or release date.
- HPLC purity result, ideally with chromatogram.
- Mass spectrometry identity confirmation.
- Theoretical molecular weight.
- Observed molecular weight or ion series.
- Acceptance criteria, such as >=98.0% or >=99.0% HPLC purity when used by the supplier.
- Lab name, reviewer, or document ID.
For Semax and Selank, a reported purity threshold of >=98% or >=99% by HPLC is common in research supplier catalogs. The number should be attached to the method and batch. A product page claim is weaker than a PDF that shows lot number, HPLC chromatogram, and MS data.
How to Read the HPLC Result
An HPLC result estimates chromatographic purity under the listed method. In practical terms, researchers should look for one dominant main peak, a stable baseline, and minor impurity peaks that are clearly separated and integrated.
For short peptides like Semax and Selank, chromatographic conditions matter. A poor method can make impurities appear cleaner than they are, especially if peaks are not well resolved. The COA should not merely say "99% pure"; it should show enough context to make the claim reviewable.
How to Read the Mass Spec Result
Mass spectrometry helps answer the identity question: does the sample match the expected peptide mass? The report may show a molecular ion, charged species, or a deconvoluted mass depending on the instrument and method. The supplier should be able to explain the observed value in relation to the theoretical value.
When reviewing Semax research peptide documentation or Selank purity research records, ask:
- Does the observed mass align with the expected sequence?
- Is the mass value for the free peptide, salt form, or observed ion?
- Is the spectrum included or available on request?
- Does the lab report identify the sample or batch?
Red Flags Specific to Semax and Selank
Semax and Selank are relatively short peptides, which makes vague supplier documentation harder to justify. Watch for these red flags:
| Red flag | Why it matters |
|---|---|
| No sequence listed | Short peptides should be easy to identify by sequence |
| HPLC purity only, no MS | Purity does not prove identity |
| Product page says "98%+" but no batch COA is available | Marketing claim is not a procurement record |
| Same COA reused for Semax and Selank | Different sequences require separate identity data |
| No lot number on vial or document | COA cannot be matched to the received material |
| Therapeutic or consumer-use claims | Research supplier copy should remain research-only |
| Unexplained mass mismatch | Could reflect salt form, adduct, or wrong identity and must be clarified |
Quality Checklist for Semax and Selank Research Peptides
Use this checklist before accepting Semax or Selank documentation for a procurement file.
Batch Matching
- Confirm the product name on the COA matches the vial label.
- Confirm the lot number on the vial matches the COA.
- Save a copy of the product page, invoice, and COA together.
- Ask the supplier to confirm whether the COA is for the current lot.
Identity Review
- Confirm the sequence appears on the COA or specification sheet.
- Confirm the theoretical molecular weight is listed.
- Confirm MS identity data is included or available.
- Review whether the supplier reports free peptide, acetate, TFA, HCl, or another salt form.
Purity Review
- Confirm HPLC or UPLC purity is listed.
- Review whether the acceptance criterion is stated.
- Look for a chromatogram or supporting HPLC report.
- Avoid relying on "lab tested" language without data.
Storage and Handling Notes
Storage notes should come from the supplier label or specification sheet. For lyophilized research peptides, many suppliers provide temperature and light exposure guidance, but storage language is not a substitute for stability testing. If stability matters for your research workflow, request stability documentation or confirm how the supplier defines shelf-life.
Do not treat supplier storage notes as instructions for human or veterinary use. Vespera products are research materials only.
Supplier Questions for Semax and Selank Procurement
Use specific documentation questions when contacting a supplier. These questions are more useful than broad claims about quality.
- Can you provide the batch-specific Semax or Selank COA for the current lot?
- Does the COA include both HPLC purity and MS identity data?
- Is the molecular weight listed for the free peptide, salt form, or observed MS ion?
- Does the vial lot number match the COA lot number?
- Can you provide the HPLC chromatogram if it is not already included?
- Was the analysis performed in-house, by a third-party lab, or both?
- Are Semax and Selank documented separately if they are listed as a paired product or blend?
For any Semax/Selank blend listing, ask whether the supplier can document each component identity and the blend batch record. A blend name is not a substitute for component-level analytical evidence.
Semax and Selank Blend Documentation
Some buyers search for Semax and Selank together because paired listings are common in the broader peptide market. For a research supplier, a blend or paired product requires more documentation, not less.
If a listing describes a Semax/Selank blend, researchers should verify:
- The exact amount or ratio of each component if the product is a true blend.
- Separate identity support for Semax and Selank.
- A batch record for the finished blend.
- HPLC method suitability for resolving both components and related impurities.
- MS identity data for each peptide or a clear validated approach for the blend.
- Lot number matching between product label, COA, and order record.
If Semax and Selank are sold as separate products, each should have its own COA/spec record. Do not assume that a COA for one peptide says anything about the other.
Downloadable Checklist Suggestion
Suggested lead magnet: Semax and Selank COA Review Checklist for Research Buyers.
Include these fields in the PDF:
| Checklist field | Semax | Selank |
|---|---|---|
| Product page saved | ||
| SKU confirmed | ||
| Lot number recorded | ||
| Sequence verified | ||
| HPLC purity reviewed | ||
| MS observed mass reviewed | ||
| COA date recorded | ||
| Storage label saved |
CTA placement: Download the Semax and Selank COA Checklist.
Vespera Trust Section: View Our Verified Semax and Selank COAs
Vespera organizes research peptide listings around product identity, SKU clarity, and documentation support.
- View Vespera Semax (10mg)
- View Vespera Selank (10mg)
- Browse cognitive and neuroprotective research peptides
- Request available Semax or Selank COA/spec documentation
When requesting documents, include product name, SKU, order number or purchase email, and lot number if available. This helps match the request to the correct batch record.
Analytical Reference Notes
COA review should be grounded in general analytical chemistry principles. HPLC separates components and estimates chromatographic purity. Mass spectrometry compares observed mass signals with theoretical peptide mass. Public chemical records such as PubChem Semax and PubChem Selank can be useful cross-checks for formula and mass context, while supplier COAs should still control batch-specific review. Analytical validation frameworks such as ICH Q2(R2) emphasize method characteristics like specificity, accuracy, precision, and range. FDA bioanalytical guidance also highlights documentation expectations for chromatographic and mass spectrometric methods in regulated analytical contexts. Research peptide COAs are not regulatory filings, but the same logic applies: state the method, show the result, and make the record traceable.
Conclusion
Semax and Selank are best compared through documentation quality: sequence identity, molecular weight basis, HPLC purity, mass spectrometry confirmation, and lot-level traceability. A clean supplier record should let a researcher connect the product page, vial, batch number, and COA without guessing.
For reproducible research procurement, do not accept generic PDFs or unsupported purity claims. Request batch-matched documentation, save the COA with your receiving records, and use transparent suppliers that make verification easy.
Browse Vespera research peptides: Semax and Selank. Request available documentation: COA / Specs Request.
FAQ
What should a Semax COA include?
A Semax COA should include product name, sequence or identity reference, lot number, HPLC purity result, mass spectrometry identity data, theoretical and observed molecular weight, test date, and lab or supplier document details.
What are Selank specifications?
Selank specifications usually include product identity, sequence, molecular weight, purity acceptance criteria, appearance, storage label, and batch documentation fields. A batch COA should report actual test results for the lot.
What is the main Semax vs Selank documentation difference?
The sequences differ: Semax is commonly listed as MEHFPGP, while Selank is commonly listed as TKPRPGP. Because they are different peptides, each should have separate identity and purity documentation.
Is HPLC purity enough to verify Semax or Selank?
No. HPLC purity estimates chromatographic purity under the listed method. Mass spectrometry is needed to help confirm peptide identity.
What purity threshold should I look for?
Many research suppliers list >=98% or >=99% HPLC purity for Semax and Selank. The threshold should appear with an actual batch result, method label, and ideally chromatogram support.
Why might molecular weight differ between sources?
Differences can reflect free peptide vs salt form, counterions, hydration, adducts, or whether the report shows a charged MS ion. Ask the supplier to explain the basis for the listed value.
Does this guide provide dosing or use instructions?
No. This guide is strictly for research procurement and documentation review. It does not provide dosing, administration, medical advice, or consumer-use guidance.
How can I request Vespera Semax or Selank documentation?
Use the COA / Specs Request page and include the product name, SKU, order details, and lot number if available.